Literature DB >> 15632172

Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors.

Michael L Goodson1, Brian A Jonas, Martin L Privalsky.   

Abstract

Many eukaryotic transcription factors are bimodal in their regulatory properties and can both repress and activate expression of their target genes. These divergent transcriptional properties are conferred through recruitment of auxiliary proteins, denoted coactivators and corepressors. Repression plays a particularly critical role in the functions of the nuclear receptors, a large family of ligand-regulated transcription factors involved in metazoan development, differentiation, reproduction, and homeostasis. The SMRT corepressor interacts directly with nuclear receptors and serves, in turn, as a platform for the assembly of a larger corepressor complex. We report here that SMRT is expressed in cells by alternative mRNA splicing to yield two distinct variants or isoforms. We designate these isoforms SMRTalpha and SMRTtau and demonstrate that these isoforms have significantly different affinities for different nuclear receptors. These isoforms are evolutionarily conserved and are expressed in a tissue-specific manner. Our results suggest that differential mRNA splicing serves to customize corepressor function in different cells, allowing the transcriptional properties of nuclear receptors to be adapted to different contexts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632172      PMCID: PMC2720035          DOI: 10.1074/jbc.M411514200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  91 in total

1.  Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor.

Authors:  S M Yoh; M L Privalsky
Journal:  J Biol Chem       Date:  2001-02-21       Impact factor: 5.157

2.  Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors.

Authors:  X Hu; Y Li; M A Lazar
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 3.  Physiological and molecular basis of thyroid hormone action.

Authors:  P M Yen
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

Review 4.  Nuclear hormone receptors and gene expression.

Authors:  A Aranda; A Pascual
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

5.  Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.

Authors:  P Pissios; I Tzameli; P Kushner; D D Moore
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

Review 6.  Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor gamma resistance.

Authors:  V K Chatterjee
Journal:  Biochem Soc Trans       Date:  2001-05       Impact factor: 5.407

7.  Isoform-specific transcriptional regulation by thyroid hormone receptors: hormone-independent activation operates through a steroid receptor mode of co-activator interaction.

Authors:  Z Yang; M L Privalsky
Journal:  Mol Endocrinol       Date:  2001-07

8.  The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.

Authors:  R N Cohen; S Brzostek; B Kim; M Chorev; F E Wondisford; A N Hollenberg
Journal:  Mol Endocrinol       Date:  2001-07

9.  Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.

Authors:  A Matsushita; H Misawa; S Andoh; H Natsume; K Nishiyama; S Sasaki; H Nakamura
Journal:  J Endocrinol       Date:  2000-12       Impact factor: 4.286

10.  The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs).

Authors:  P Webb; C M Anderson; C Valentine; P Nguyen; A Marimuthu; B L West; J D Baxter; P J Kushner
Journal:  Mol Endocrinol       Date:  2000-12
View more
  39 in total

1.  EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.

Authors:  Daniel Portal; Bo Zhao; Michael A Calderwood; Thomas Sommermann; Eric Johannsen; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β.

Authors:  Brenda J Mengeling; Michael L Goodson; William Bourguet; Martin L Privalsky
Journal:  Mol Cell Endocrinol       Date:  2012-01-12       Impact factor: 4.102

3.  Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation.

Authors:  Michael L Goodson; Brenda J Mengeling; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

4.  Multiple mutations contribute to repression by the v-Erb A oncoprotein.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

5.  Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs.

Authors:  I H Chan; M L Privalsky
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

6.  Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity.

Authors:  Meghan D Rosen; Martin L Privalsky
Journal:  Mol Endocrinol       Date:  2009-04-30

7.  Estrogen receptors recruit SMRT and N-CoR corepressors through newly recognized contacts between the corepressor N terminus and the receptor DNA binding domain.

Authors:  Natalia Varlakhanova; Chelsea Snyder; Soumia Jose; Johnnie B Hahm; Martin L Privalsky
Journal:  Mol Cell Biol       Date:  2010-01-11       Impact factor: 4.272

8.  A cautionary note as to the use of pBi-L and related luciferase/transgenic vectors in the study of thyroid endocrinology.

Authors:  Ivan H Chan; Alexander D Borowsky; Martin L Privalsky
Journal:  Thyroid       Date:  2008-06       Impact factor: 6.568

9.  Molecular mechanisms of transcriptional control by Rev-erbα: An energetic foundation for reconciling structure and binding with biological function.

Authors:  Anaïs Vaissière; Sylvie Berger; Deborah Harrus; Catherine Dacquet; Albane Le Maire; Jean A Boutin; Gilles Ferry; Catherine A Royer
Journal:  Protein Sci       Date:  2015-06-11       Impact factor: 6.725

10.  Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.

Authors:  Lei Guo; Chaoyu Chen; Qiaoling Liang; Mohammad Zunayet Karim; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2012-12-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.